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Summary Hoechst 33342 is a fluorescent dye used for cell selection from tumours based upon intratumour
location. When the dye is administered i.v. to tumour-bearing animals, cellular fluorescence is directly related
to the proximity of cells to blood vessels. The present study compared inherent Hoechst fluorescence between
in vitro-stained EMT6/Ro (mouse mammary sarcoma) cells and host cells, to determine if these populations
have different staining characteristics that may influence cell selection procedures. Tumour cell fluorescence
exceeded host cell staining by 8-fold when pure cell populations (EMT6/Ro monolayer cells, mouse spleen
and peritoneal cells) were compared, and 3-fold for tumour cell-enriched and host cell-enriched populations
from solid tumours. Inherent uptake of HO 33342 appeared to be correlated with cell volume. These
differences in inherent dye uptake between host and tumour cells were found to be minor in comparison to
the fluorescence gradient between the 10% brightest and 10% dimmest (78-fold) cell populations from in vivo-
stained tumours.
The bisbenzamide dye Hoechst 33342 (HO 33342) has been
used for the selection of cell populations from different
locations within multicellular tumour spheroids (Durand,
1982; Olive et al., 1985) and solid tumours (Chaplin et al.,
1985; Olive et al., 1985). Administration of HO 33342 to
tumour-bearing animals (via i.v. injection), or incubation of
multicellular tumour spheroids in the dye (via dilution in
tissue culture medium), results in diffusion-limited delivery of
the dye, based upon the proximity of cells to either blood
vessels supplying the tumour, or surface of the spheroid,
respectively. HO 33342 binds to cellular DNA, and at
concentrations greater than 6pgml-1, staining of cells is
based upon their DNA content; lower concentrations result
in fluorescence intensity being determined by relative cellular
metabolic activity (Loken, 1980), activation status (for
antigen- or mitogen-stimulated lymphocytes) (Lalande &
Miller, 1979), and possibly other factors as well. Cell
populations obtained from different intratumour locations
by in vivo Hoechst staining, followed by cell sorting based
upon fluorescence intensity, have been examined for
parameters such as in vitro survival, adriamycin cytotoxicity,
and resistance to radiotherapy (Chaplin et al., 1985), and for
investigation of the cell cycle distribution of chronically
hypoxic cells within solid tumours (Pallavicini et al., 1979).
Many types of murine and human tumours are
significantly infiltrated by host cells, primarily macrophages,
neutrophils, and lymphocytes (Witz & Hanna, 1980).
However, studies of HO33342 for cell selection in tumours
have until now focused primarily upon staining of the
tumour cell population, and direct comparisons of Hoechst
staining of host and tumour cells have not been made. In
order for HO 33342 to be useful for selection of cells based
upon location with tumours, it is necessary that significant
differences in fluorescence intensity between cells result only
from differences in location and not from inherent variations
in staining between host and tumour cells. The objectives of
the present study were to compare inherent HO 33342
fluorescence between host and tumour cells, and to
determine the usefulness of HO 33342 staining as a method
for cell selection in the EMT6 mouse mammary tumour,
which contains a significant proportion of infiltrated host
cells (Lord, 1980).
Correspondence: E.M. Lord.
Received 22 January 1987; and in revised form, 19 May 1987.
Materials and methods
Tumour cell line
EMT6 is a spontaneous mouse mammary sarcoma of
BALB/c origin adapted for tissue culture by Rockwell et al.,
(1972). The University of Rochester subline, EMT6/Ro, was
used in these experiments. Solid tumours were grown i.m. in
the rear legs of BALB/cByJ mice as described previously
(Lord, 1980), except that EMT6/Ro cells were initially grown
as monolayers in serum-free medium (Taupier et al., 1985)
prior to injection into mice.
Preparation ofcell suspensions
BALB/c mice were euthanized by cervical dislocation, and
peritoneal cells were collected by lavage with balanced salt
solution (BSS) containing 5Uml-1 heparin. Spleens were
removed and single cell suspensions prepared.
Exponentially-growing EMT6/Ro monolayers were
dissociated to single cell suspensions by treating for 2min
with 0.005% trypsin and then washed twice with cold BSS.
Solid EMT6/Ro tumours (0.5-1.0g) were removed from
groups of 3-4 mice, minced finely, and digested with 0.2%
collagenase (Sigma #C-0130, 20mlg-1 of tumour) at 37°C
for 1 h. Cells from tumours of similar weight were pooled
and centrifugal elutriation was used to separate cells into
host and tumour cell populations, as previously described
(Lord & Keng, 1984).
Staining with HO 33342
In vitro staining of single cell suspensions was done by
incubating 3 xl10 cells ml-' in 0.03pgml-' HO 33342 in
phosphate buffered saline (PBS) for 5min at 37°C with
gentle rocking. The cells were washed in BSS and
resuspended at 3 x 106ml-1 in PBS for flow cytometric
analysis.
For in vivo staining of solid EMT6/Ro tumours, HO33342
(0.25ml of a 1 mgml-1 concentration in sterile saline) was
injected i.v. into groups of mice with 0.5-1.0g tumours.
After 20min, the mice were sacrificed, tumours removed,
and single cell suspensions prepared as described above.
Equal numbers of cells from each of the 3 tumours were
pooled and resuspended in PBS at 5 x 106 cells ml-1 for flow
cytometric analysis. In order to examine the effects of
pooling cells from tumours, in one experiment fluorescence
intensity from 3 individual tumours was analyzed, as well as
fluorescence of a pooled cell sample. In order to investigate
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the in vivo staining patterns of host cells and tumour cells
separately, in some experiments the single cell suspensions
from in vivo-treated tumours were separated by centrifugal
elutriation to isolate host cell-enriched and tumour cell-
enriched fractions for flow cytometric analysis.
Flow cytometry
Flow cytometric procedures were performed with a Coulter
EPICS V (Coulter Electronics, Inc., Hialeah, Fla.) with a
krypton laser (Innova 90K krypton laser by Coherent, Palo
Alto, Ca.). The laser operated at 100mW of power at an
average wavelength of 350nm. Fluorescence emissions were
monitored for wavelengths in excess of 408 nm. For
experiments involving in vitro staining of cells with
HO33342, a fluorescence histogram was generated for each
sample. For experiments involving tumour staining in vivo,
one-parameter histograms of the fluorescence distribution of
individual tumours and of the pooled tumour sample were
generated, and the fluorescence intensities of the 10%
brightest and 10% dimmest cells were calculated. The
gradient of fluorescence for each of the in vivo-stained
tumours was determined by dividing the mean fluorescence
of the 10% brightest cells by that of the 10% dimmest cells.
To quantitate the percentages of host and tumour cells in
each of these populations, DNA histograms were produced
using the mithramycin staining procedure of Crissman and
Tobey (1974). This procedure identifies cell populations on
the basis of DNA content. Since EMT6 cells are nearly
tetraploid, they are easily distinguished from the diploid host
cells. DNA histograms of the host cell-enriched and tumour
cell-enriched populations obtained from tumours by
centrifugal elutriation were also produced to evaluate the
extent to which cycling host cells (host G2M peak) might be
hidden by the tumour G1 peak. To determine the various
types of host cells present in different fractions, cytospin
preparations were made, stained with Gugol Blue (Wright-
Giemsa stain), and differential counts performed on a
minimum of 400 cells.
All experimental data were collected and analyzed by
means of Coulter Multiparameter Acquisition and Display
Systems (MDADS) and a TERAK 8600 microcomputer. The
mean fluorescence channel number (logarithmic scale) was
calculated for each histogram, as well as for the 10%
brightest and 10% dimmest populations from the in vivo-
stained tumours, then converted to a mean fluorescence
value.
Measurement ofmean cell volume
Mean cell volumes were determined by means of a Coulter
Channelizerg (Coulter Electronics).
Results
Single cell suspensions of spleen cells, peritoneal cells, and
EMT6/Ro tumour cells were stained in vitro to compare the
fluorescence of pure host and pure tumour cell populations.
Representative one-parameter histograms of fluorescence
intensity (logarithmic scale) are shown in Figure 1, and the
calculated fluorescence intensities of the various cell
populations are presented in Table I. Differences in inherent
fluorescence intensity between host and tumour cells were
clearly present; the EMT6/Ro tumour cells were found to
fluoresce more brightly than peritoneal cells and spleen cells
by 7-fold and 9-fold, respectively. Fluorescence appeared to
be related to cell volume for the various cell types.
In order to examine inherent staining differences between
subsets of cells from solid tumours, tumour-cell enriched and
host cell-enriched fractions were obtained from solid
EMT6/Ro tumours by centrifugal elutriation. Two experi-
ments, involving a total of 7 tumours, were performed. The
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Figure 1 One parameter histograms for fluorescence intensity of
(a) spleen cells, (b) peritoneal cells, and (c) EMT6/Ro cells
following in vitro staining with HO 33342 (0.03Mgml-1).
individual cell fractions were then stained in vitro, and
fluorescence was quantitated. Data are shown in Table II.
The fluorescence intensity of the tumour cell-enriched
fraction exceeded that of the host cell-enriched fraction by
an average of 3-fold. Again, inherent uptake ofdye appeared
to be related to cell volume.
These differences in dye uptake between host and tumour
cells were compared to the gradient of fluorescence between
brightest and dimmest cells in solid tumours stained in vivo.
This was done to determine if the inherent staining
differences between host and tumour cells were sufficiently
large to influence the selection of cell populations from
different intratumour locations based upon in vivo Hoechst
staining. The fluorescence intensities of the 10% brightest
cells and 10% dimmest cells from each of 3 tumours of
similar size were compared. A pooled sample consisting of
equal numbers of cells from each of the 3 tumours was also
evaluated. Fluorescence of the 10% brightest cells exceeded
that of the 10% dimmest cells by an average of 78-fold
(Table III). Thus, the gradient of fluorescence intensity in in
vivo-stained tumours was far greater than the small inherent
staining differences between tumour cells and host cells.
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Table I Fluorescence intensity of splenocytes, peritoneal cells, and EMT6/Ro tumour cells
following in vitro staining with HO 33342
Mean Mean (Meanfluorescencel
Cell type fluorescence +s.e. volume+s.e.(um3) Mean volume) x 102
EMT6/Ro 52+4 2,544a 2.0
Peritoneal cells 7+2 218+7 3.2
Spleen cells 6+1 137+3 4.3
aVolume was calculated for only 1 sample of EMT6/Ro cells. (Each value for fluorescence
represents mean of 6 samples; volumes for peritoneal and spleen cells represent mean of 3
samples.)
Table II Fluorescence intensity of host- and tumour-enriched fractions from EMT6/Ro tumours, separated
by centrifugal elutriation and stained in vitro
% % Mean Mean (Meanfluorescencel
Fraction EMT6 Host cells fluorescence volume (,m3) Mean volume) x 102
Host cell-enriched 4 96 10 346 2.9
Tumour cell-enriched 86 14 31 2,008 1.5
(Data are means from 2 experiments, involving a total of 7 tumours.)
Table III Fluorescence gradient between brightest 10% and dimmest 10% cell populations in in
vivo - stained EMT6/Ro tumours
Fluorescence Fluorescence Ratio offluorescence of
ofdimmest ofbrightest 10% brightest to
Tumour no. 10% cells 10% cells 10% dimmest cells
1 3 259 86
2 3 221 74
3 3 225 75
Mean+s.e. for 3 tumours 3+ 0 235+ 12 78+4
Pooled sample 3 240 80
Table IV Fluorescence intensity of host- and tumour-enriched fractions from in vivo-stained tumours
Ratio of
Fluorescence Fluorescence fluorescence of
Predominant Mean of10% dimmest of 10% brightest 10% brightest to
Fraction no. cell type fluorescence cells cells 10% dimmest cells
1 lymphocytesa 11 2 158 79
4 macrophagesb 28 3 203 68
9 EMT6/Roc 34 6 162 27
Pooled assortedd 28 3 240 80
'8% EMT6/Ro, 5% neutrophils, 78% lymphocytes, 9% macrophages; b2% EMT6/Ro, 1% neutrophils, 10% lymphocytes,
87% macrophages; C89% EMT6/Ro, 11% macrophages; d64% EMT6/Ro, 2% neutrophils, 3% lymphocytes, 31%
macrophages.
The gradient of fluorescence between the 10% brightest
and 10% dimmest cells was examined separately for host
cell-enriched and tumour cell-enriched populations obtained
from in vivo-stained tumours by centrifugal elutriation. The
gradients for both lymphocyte-enriched and macrophage-
enriched fractions were found to be similar to the gradient
for pooled (unfractionated) cells (79,68, and 80-fold,
respectively); the gradient for tumour cells was found to be
smaller (27-fold), however (Table IV).
In this experiment, the fluorescence values for the 10%
brightest and 10% dimmest cell populations from the pooled
sample were quite similar to the individual values for each of
the 3 tumours (Table III). The one-parameter histograms
of fluorescence intensity of the pooled sample and of the
3 individual tumours were virtually undistinguishable
(Figure 2).
The cell composition of the 10% brightest and 10%
dimmest fractions was evaluated by DNA analysis (mithra-
mycin staining procedure) and by differential counts on
cytospin preparations, to quantitate the relative percentages
of host and tumour cells in each fraction. Three in vivo-
stained tumours were pooled, sorted, and the resulting cell
fractions evaluated by DNA analysis and differential counts.
DNA histograms are shown in Figure 3. The unsorted
tumour contained 48% host cells/52% tumour cells, the 10%
brightest fraction was composed of 64% host cells/36%
tumour cells, and the 10% dimmest fraction contained 82%
host cells/18% tumour cells. One-parameter histograms of
mithramycin-stained host cell-enriched and .tumour cell-
enriched fractions obtained by centrifugal elutriation (Figure
4) indicated that most of the tumour cells and host cells were
in the G1 phase of the cell cycle.574 D.A. LOEFFLER et al.
Table V Differential cell counts of various fractions from in vivo-stained EMT6/Ro
tumours
Fraction EMT6 Neutrophils Lymphocytes Macrophages
Unfractionated 52 8 3 37
10% brightest cells 24 4 14 58
10% dimmest cells 19 28 14 39
(Three tumours of 20 days duration were stained in vivo, and equal numbers of cells
from each were pooled prior to sorting.)
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Figure 2 One parameter histograms for fluorescence intensity of in vivo stained tumours: (a) tumour no. 1, (b) tumour no. 2, (c)
tumour No. 3, (d) pooled (composite) sample of equal numbers of cells from tumours no. 1, 2, and 3.
Discussion
The inherent dye uptake of EMT6/Ro tumour cells was
found to exceed that of host cells by 7-to-9-fold when pure
populations were compared, and by 3-fold when cell
fractions from solid tumours were compared. These inherent
staining differences were small in comparison to the gradient
of fluorescence (78-fold) between the brightest 10% and
dimmest 10% cells for in vivo-stained tumours. These data
indicate that the various subsets of cells within solid tumours
may differ in their uptake of HO 33342; but, for the
EMT6/Ro tumour, the inherent staining differences are
sufficiently small (relative to the in vivo dye gradient) that
the dye is useful for selection of cells from different locations
within the tumour.
This study represents the first direct comparison of
Hoechst staining of host and tumour cells from solid
tumours. Olive et al. (1985) examined HO 33342 binding
rates for SCCVIJ/St murine carcinoma cells initially stained
in vivo, then sorted into 4 equal populations on the basis of
fluorescence intensity, and exposed to additional dye.
Subsequent dye-binding rates varied 2-fold between the
brightest and dimmest cell populations. It was concluded
that, for the SCCVIJ/St tumour, uptake of HO 33342 by
cells depended largely upon intratumour location. We have
reached a similar conclusion for the EMT6/Ro tumour by
direct comparison of dye uptake of host and tumour cells.
The ratios of tumour cell to host cell inherent fluorescence
varied from 7-9-fold for experiments with 'pure' cell
populations, to 3-fold for tumour- and host-enriched
fractions from solid tumours. Several factors may have been
involved in these differences between the pure populations
and the tumour-associated cells. The mean cell volume for
EMT6/Ro monolayer cells (2,544um3) was greater than for
the EMT6/Ro tumour-enriched cells (2,008pm3), which may
have contributed to the greater mean fluorescence intensity
of the monolayer (52 vs. 31). The smaller volume for the
tumour-enriched cells was due, in part, to contamination by
host cells; however, EMT6/Ro cells from solid tumours are
indeed found to be smaller than EMT6/Ro monolayer cells
(P. C. Keng, unpublished data).
Staining patterns with tumours treated in vivo with
HO 33342 are reported to be more variable than for multi-
cellular spheroids, due to variabilities in tumour blood flow
and injection technique (Olive et al., 1985). In the present
report, however, in vivo staining of tumours of comparable
size was found to result in fluorescence distributions that
were extremely similar. A composite sample consisting of
equal numbers of cells from 3 in vivo-stained tumours pro-
duced a fluorescence distribution indistinguishable from
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Figure 3 DNA histograms for in vivo-stained EMT6/Ro
tumours: (a) unfractionated cells, (b) 10% brightest cells, (c) 10%
dimmest cells.
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those of the 3 individual tumours. It is concluded that the
slight 'averaging' effect of pooling did not appreciably alter
the measurement of the gradient of fluorescence for the solid
tumours.
It was of interest that the fluorescence gradient between
the brightest and dimmest host cells cells was much greater
than the corresponding gradient for tumour cells. This may
indicate that the tumour cells are concentrated more in the
middle of the tumour than in the perivascular area and near
the necrotic center. The present report evaluated only the
brightest and dimmest 10% cell populations, and these
fractions were in fact found to be enriched for host cells.
Examination of histologic sections of EMT6/Ro tumours
revealed accumulations of mononuclear cells around
prominent arterioles at the tumour margins, and numerous
neutrophils at the junction of the normal tumour tissue with
the necrotic center (D. Loeffler, unpublished observations).
Accumulations of host cells in these areas may explain the
finding of the 10% brightest and 10% dimmest cell fractions
being enriched for host cells, compared to the unsorted cell
population. A future study will examine the percentages of
host and tumour cells in all fractions from the 10% brightest
to the 10% dimmest cells.
As the time necessary for collagenase digestion of tumours
was relatively long (1Hh), some redistribution of the dye
from brightly-stained cells to the more dimly stained
population undoubtedly occurred during this time. Olive
et al. (1985) have previously addressed the issue of
redistribution of HO 33342 in solid tumours and spheroids;
they found that some dye redistribution did occur, leading to
a gradual decrease over time in the measured gradient
between the brightest and dimmest-staining cells. However, a
large gradient between the brightest and dimmest cells
remained even after several hours. In the present report, a
large gradient was present 1 -2h after tumour treatment.
Although the gradient immediately after in vivo staining was
probably of even greater magnitude, the binding of
HO33342 to the EMT6/Ro cells was sufficient to allow cell
sorting on the basis of fluorescence intensity several hours
later.
The EMT6 tumour has been found to contain up to 33%
hypoxic cells (Rockwell & Kallman, 1973). Cells in the 10%
dimmest population presumably are hypoxic in vivo,
although the association between Hoechst fluorescence and
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Figure 4 DNA histograms for host-enriched and tumour-enriched populations separated from EMT6/Ro tumours by centrifugal
elutriation: (a) Fraction 1 (primarily host cells, lymphocyte-enriched); (b) Fraction 4 (primarily host cells, macrophage-enriched); (c)
Fraction 9 (primarily EMT6/Ro tumour cells); (d) pooled (unfractionated) cells. T indicates host cell G1 peak, tt indicates tumour
cell G, peak.
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oxygenation status is an indirect one. In contrast, the 10%
brightest cells, i.e., those cells located close to the tumour
vascular supply, presumably are well-oxygenated in vivo.
Hoechst staining thus constitutes a useful method for
determining the host cell populations present in well-
oxygenated and hypoxic areas of the EMT6/Ro tumour. Use
of the flow cytometer to separately collect these populations
will allow parameters such as cell surface antigens and
biological activity to be compared for host cells from
different areas within the tumour.
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